Tumour necrosis factor-α blockers in the treatment of psoriasis.
The Mount Sinai Medical Center, New York, NY, USA. Lebwohl@aol.com
M
M
Lebwohl
D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003141:Communicable Diseases / Q000139:chemically induced*; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced*; D011565:Psoriasis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000893:Anti-Inflammatory Agents; D014409:Tumor Necrosis Factor-alpha